Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Orelabrutinib
(D12160)		[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬[1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[4] 13, 49, 61, 63 💬
2Orelabrutinib (High Dose)
(D12160)		[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬[1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
3Orelabrutinib (Low Dose)
(D12160)		[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬[1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
4Orelabrutinib( higher dose)
(D12160)		[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬[1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
5Orelabrutinib( lower dose)
(D12160)		[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬[1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬